Download presentation
Presentation is loading. Please wait.
Published byWilla Gilbert Modified over 9 years ago
1
environmental • failure analysis & prevention • health • technology development
A leading engineering & scientific consulting firm dedicated to helping our clients solve their technical problems.
2
Center for Toxicology & Mechanistic Biology
Emerging Issues in Industrial Hygiene – The Impact of Biomonitoring Data Sol Bobst, PhD Senior Scientist Center for Toxicology & Mechanistic Biology EXPONENT, Inc. Houston, Texas Tel: GSM: FAX:
3
Biomonitoring Overview
What is it? Intended Uses Interpretation TLV / BEI Evaluation Process Resources Acknowledgements
4
What is Biomonitoring? “Biomonitoring,” is defined in the environmental public health field as the assessment of human exposure to an environmental chemical via the measurement of that chemical, its metabolites, or reaction product(s) in human blood, milk, urine, saliva, adipose, or other tissue in individuals (in a population). Needham: Int J Hyg Env Health, 2006
5
Why is it important to the Practice of Industrial Hygiene?
Identification Evaluation Control
6
Current Consensus Biomonitoring Data are being generated and published faster than regulators and professionals can analyze and interpret them. There is a need for well defined guidelines for interpreting biomonitoring data. There is a need to understand how biomonitoring data should be utilized in a risk evaluation framework for regulators and industrial stakeholders. There is a need to clearly communicate that biomonitoring data do not substantiate a human health risk and disease.
7
Intended Uses for Biomonitoring
Provide a metric of exposure for use in risk assessment. Monitor/Idenitfy exposure trends within a population. Use available tools to provide the basis for more effective design of approved studies / risk assessments.
8
Use in Risk Assessment Establish & Characterize Exposure / Trends.
Investigate “linkages” between exposure and adverse health effects. Facilitate Risk Management. ECOTOC Document 44, November 2005
9
The Challenge The Production of Biomonitoring Data, or utility of a Biomonitoring Study, often does not address all of the requirements for rigorous and effective risk evaluation. What does the data mean? How is it useful? What is inappropriate interpretation?
10
Issues in Biomonitoring
Data Quality Interpretation Ethics Transperency Biomonitoring vs. Biomarkers
11
Data Quality Requirements – Must address intended use, but also evaluate potential use Methodology, Study Design, Calibrations Technical Quality
12
Interpretation of Biomonitoring
Analytical Integrity Standardized Methodology, (local vs. international standards) Recovery, Reproducibility Accounting for false positives/contamination
13
Ability to Describe Exposure Requires Toxicokinetics
Routes of Exposure Endogenous Contribution Pharmacokinetics/Pharmacodynamics of Absorption, Distribution, Metabolism, Excretion Genotoxic Effects Forward or Reverse Extrapolation of Dose
14
Exposure – Effect Continuum
15
Benefits of Including Biomonitoring Evaluation into Industrial HSE Policy
Enhance Risk Management. Case by Case evaluation of chemical specific Biomonitoring can result in effective guidance for data development of: Animal testing Methodologies for assessing human exposure IH sampling. Save Time, Resources, Money.
16
Shift in Focus From External Exposure Concentrations to Internal Dose Estimation. Future Regulatory Decisions may set exposure guidelines (EPA, OSHA, TCEQ) based on BEI(s), or Biomonitoring / Biomarker indices.
17
Biomonitoring Interpretation in Industrial Hygiene
ACGIH Process for Evaluating TLV/BEI Opportunity for Involvement
18
Interpretation Define Limitations
Example – One Person – One Blood Sample – One Test!!!!! NHANES Study, CDC Account for Variability – Population Context Age, Gender, Sample Volume, Geographical Location of Sample
19
Biomarker Evaluation is an Important Step in Interpreting Biomonitoring Data
Biomarker vs. Biomonitoring Data Biomonitoring: Arsenic in Hair (Chemical in Fluid/Tissue/Matrix) Biomarker: DNA Adduct (Metric of Metabolism / Biological Mechanism) Measure of Chemical Metabolite in Biological Fluid/Tissue. Accurate Metric for Understanding External Exposure.
20
Biomarker Evaluation is an Important Step in Interpreting Biomonitoring Data
21
Feedback What Concerns or Issues in Biomonitoring are important to you?
22
Public Resources for Biomonitoring
ECOTOC Report NAS Report Other
23
ECETOC Report (European Centre for Ecotoxicology & Toxicology of Chemicals)
Guidance for the Interpretation of Biomonitoring Data, Document No. 44, Brussels, November 2005. Establishes Framework for evaluating biomonitoring data for risk assessment. More Detailed Guidelines on Interpretation Examples: Parabens, Hexachlorobutadiene
24
NAS Report Human Biomonitoring for Environmental Chemicals (NRC – NAS 2006). Conclusions: There is a need for a consistent rationale for selecting chemicals for study based on exposure and public-health concerns. Appropriate Statistical Principles Need to be Applied when sampling populations. Recommend that biomonitoring program sponsors require planning for communication and evaluation. for any applied use.
25
Other Biomonitoring.info – Environmental Health Research Foundation CDC – National Biomonitoring Program:
26
Acknowledgements Exponent Biomonitoring Team Angelina Duggan
Elizabeth Anderson Ben Thomas Louis Bloemen Sanjeev Saraf Martin Barrie
27
References Guidance for the Interpretation of Biomonitoring Data, Document No. 44, Brussels, November 2005, ECOTOC. Needham, Calafat, Barr “Uses and issues in biomonitoring” Int J Hyg Environ Health 2007 May;210(3-4): Epub 2006 Dec 8. Albertini , Bird , Doerrer, Needham, Robison, Sheldon, Zenick. “The use of biomonitoring data in exposure and human health risk assessments.” Environ Health Perspect Nov;114(11): Doerrer “Integration of human biomonitoring exposure data into risk assessment: HSEI intiatives and perspectives Int J Hyg Environ Health ;
28
Report Website Links NAS Biomonitoring Report - ECETOC Report -
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.